What is the purpose of this trial?
The purpose of this study is to determine the efficacy and safety of investigational drug relatlimab plus nivolumab in combination with chemotherapy in participants with unresectable, untreated, locally advanced or metastatic gastric or GEJ cancer.
Bristol-Myers Squibb Research and Development
Start Date: 03/13/2019
End Date: 12/27/2020
Last Updated: 03/14/2019
Study HIC#: 2000024051